Selank peptide research overview covering tuftsin-related and enkephalin hypotheses, limited human evidence, safety boundaries and COA verification.
Selank is a synthetic heptapeptide derived from a tuftsin-related sequence. Research has examined anxiety-related behaviour, stress signalling and neurochemical mechanisms.
Published human evidence is small and concentrated in a limited set of research settings. It does not support replacing established assessment or treatment for anxiety, depression or another mental-health condition.
Mechanism explains why a compound enters a research conversation. It does not establish that the compound is effective, appropriate or safe for a person.
Laboratory work has explored enkephalin degradation, monoamine signalling and immune-neural interactions. These pathways may explain research interest but do not establish a predictable anxiolytic effect.
The evidence base also has limited independent replication across countries, formulations and modern trial standards. Product-specific exposure is poorly characterized.
These are recurring questions in the published literature. They are research themes, not promised outcomes or personal recommendations.
Anxiolytic effect reported to be comparable to benzodiazepines in Russian clinical trials
May support cognitive clarity and mental performance under stress
Protects endogenous enkephalins, which may help support mood and emotional stability
Immunomodulatory: may reduce stress-related neuroinflammation and help normalize cytokine balance
A human/mechanistic report examined enkephalinase activity and Selank’s inhibitory effect. Other publications are often small, preclinical or difficult to generalize.
What the evidence cannot answer: This is enough to describe a hypothesis, not enough to claim treatment equivalence with licensed mental-health care or to provide a public dosing protocol.
Open the published batch report and match its COA number to the vial used in your research.
View Selank COAResearch-market naming does not establish identity, concentration or purity. A useful certificate of analysis identifies the batch, analytical method and measured result. Match the COA number to the vial rather than relying on a site-wide percentage or a study of a different product.
Independent verification: every certificate of analysis carries a code you can check yourself at Peptide Test Canada, an independent third-party testing lab — you don't have to take our word for it.
Quantum publishes an individual report for this entry and keeps the broader lab-results archive available for comparison.
New or worsening anxiety, depression, suicidality, mania, psychosis or functional decline requires timely professional assessment—not quiz-based peptide matching.
Product status: Selank is not represented by Quantum as an authorized anxiety medicine and is supplied for laboratory research only.
The tracker defines one cognitive or stress outcome and records sleep, mood, medications and neurological changes.
Cadence, timing and cycle are owner-draft previews. Dose, dilution, titration, inventory, check-ins and change history remain inside the tracker after purchase.
Concise answers that keep mechanism, evidence, product quality and regulatory status separate.
Selank is a synthetic heptapeptide derived from a tuftsin-related sequence. Research has examined anxiety-related behaviour, stress signalling and neurochemical mechanisms.
Laboratory work has explored enkephalin degradation, monoamine signalling and immune-neural interactions. These pathways may explain research interest but do not establish a predictable anxiolytic effect.
A human/mechanistic report examined enkephalinase activity and Selank’s inhibitory effect. Other publications are often small, preclinical or difficult to generalize. Large blinded trials, standardized outcomes, independent replication, human pharmacokinetics and long-term safety are missing.
Selank is not represented by Quantum as an authorized anxiety medicine and is supplied for laboratory research only.
This educational page does not provide a protocol. Published exposure, when available, is specific to the studied or authorized product and cannot be transferred to Quantum’s research-use-only material. Use the tracker only as an organizational record, not a substitute for qualified medical care.
Use the individual batch report to verify identity, analytical method, reported purity and COA number. Match that number to the vial; a general purity claim is not batch verification.